class="info-alert">『Your web browser does not support JavaScript, but it does not affect browsing through the rest of the web site.』
jump to main content

Industrial Technology Research Institute


A Novel IOP Reducing Agent for Glaucoma

Technology Overview

A Novel IOP Reducing Agent for Glaucoma.
A Novel IOP Reducing Agent for Glaucoma.

Glaucoma, the second leading cause of blindness, requires new medications as current treatments and surgeries may cause drug resistance, waning effectiveness, and side effects within 1 to 3 years in 50% of the patients after long-term medication. ITRI developed a novel agent for glaucoma that is effective in reducing intraocular pressure (IOP) and preventing eye irritation. The drug works by relaxing the eye’s trabecular meshwork (TM) and allowing the aqueous humor (AH) to flow out, thereby lowering the IOP. Pre-clinical studies for preparing phase I IND package have been completed and the technology has been transferred to pharmaceutical companies in Taiwan. T

Applications & Benefits

This innovation makes an advance in glaucoma treatment and is expected to drive the pharmaceutical industry to capture the niche market of ophthalmic drugs.

One-Stop Biomedical Services

One-Stop Biomedical Services

  • Listing Regulations Consulting: FDA/TFDA/CE application, medical device verification/export, medical device/medicine registration, IRB document organization, clinical trial application, and more.
  • Technology Transfer: Bio-IT, diagnostics and precision medicine technology, regeneration medicine technology, natural medicine and healthcare technology, targeted drug and delivery technology.
  • Model Translation: Domestic supply chain linkage, medical device design control, market analysis, strategy analysis of regulation in commercialization, and more.
  • Preclinical / Clinical Trial: Functional safety assessments, clinical research organization linkage, clinical evaluation and analysis, clinical trial planning, clinical trial analysis and reports.
  • Other Services: Quality system consulting, commercialization consulting, smart health solutions, software validation, medical device risk management, information security risk evaluation, technical documents preparation, business ecosystem linkage, and more.